BluSense Diagnostics Overview
- Year Founded
-
2014
- Status
-
Out of Business
- Employees
-
42
- Latest Deal Type
-
Out of Business
- Investors
-
1
BluSense Diagnostics General Information
Description
Developer of a blood testing device designed to diagnose infectious diseases. The company's consumer-oriented blood testing device is based on a nanotechnology biosensing method that can deliver results with a single drop of blood, enabling people to monitor, control and manage virus outbreaks.
Contact Information
Website
www.blusense-diagnostics.comCorporate Office
- Fruebjergvej 3
- 2100 Copenhagen
- Denmark
Corporate Office
- Fruebjergvej 3
- 2100 Copenhagen
- Denmark
BluSense Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Out of Business | 16-May-2024 | Completed | Out of Business | |||
| 7. Later Stage VC (Series C) | Cancelled | Generating Revenue | ||||
| 6. Later Stage VC | 31-Dec-2020 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 31-Dec-2019 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 26-Apr-2018 | Completed | Generating Revenue | |||
| 3. Grant | 19-Dec-2017 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 12-Dec-2015 | $1.65M | $1.65M | Completed | Generating Revenue | |
| 1. University Spin-Out | 01-Aug-2014 | Completed | Startup |
BluSense Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | 40,000 | $0.148731 | $42.49 | $42.49 | 1x | $42.49 |
BluSense Diagnostics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
BluSense Diagnostics Patents
BluSense Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2023510552-A | Centrifugal microfluidic device with blocking chamber and detection chamber | Pending | 20-Jan-2020 | ||
| EP-4094065-A1 | Centrifugal microfluidic device with blocking and detection chambers | Inactive | 20-Jan-2020 |
BluSense Diagnostics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
BluSense Diagnostics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Technical University of Denmark | University | Minority |
BluSense Diagnostics FAQs
-
When was BluSense Diagnostics founded?
BluSense Diagnostics was founded in 2014.
-
Where is BluSense Diagnostics headquartered?
BluSense Diagnostics is headquartered in Copenhagen, Denmark.
-
What is the size of BluSense Diagnostics?
BluSense Diagnostics has 42 total employees.
-
What industry is BluSense Diagnostics in?
BluSense Diagnostics’s primary industry is Diagnostic Equipment.
-
Is BluSense Diagnostics a private or public company?
BluSense Diagnostics is a Private company.
-
What is BluSense Diagnostics’s current revenue?
The current revenue for BluSense Diagnostics is .
-
How much funding has BluSense Diagnostics raised over time?
BluSense Diagnostics has raised $9.5M.
-
Who are BluSense Diagnostics’s investors?
Technical University of Denmark has invested in BluSense Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
